Akebia Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
AKBA
CUSIP
00972D105
Type
Equity
Class
COM
Num filers
105
Total reported value, excl. options
$57.4M
Manager Report Date Value ($000) Shares